Kim EM - Search Results

1

Role of matrix metalloproteinase-3 in neurodegeneration.

Kim EM, Hwang O. Kim EM, et al. J Neurochem. 2011 Jan;116(1):22-32. doi: 10.1111/j.1471-4159.2010.07082.x. Epub 2010 Dec 2. J Neurochem. 2011. PMID: 21044079 Free article. Review.

2

A novel intracellular role of matrix metalloproteinase-3 during apoptosis of dopaminergic cells.

Choi DH, Kim EM, Son HJ, Joh TH, Kim YS, Kim D, Flint Beal M, Hwang O. Choi DH, et al. Among authors: kim d, kim em, kim ys. J Neurochem. 2008 Jul;106(1):405-15. doi: 10.1111/j.1471-4159.2008.05399.x. Epub 2008 Jul 1. J Neurochem. 2008. PMID: 18397366 Free article.

3

Matrix metalloproteinase-3 contributes to vulnerability of the nigral dopaminergic neurons.

Kim ST, Kim EM, Choi JH, Son HJ, Ji IJ, Joh TH, Chung SJ, Hwang O. Kim ST, et al. Among authors: kim em. Neurochem Int. 2010 Jan;56(1):161-7. doi: 10.1016/j.neuint.2009.09.014. Epub 2009 Oct 6. Neurochem Int. 2010. PMID: 19815046

4

Matrix metalloproteinase-3 is increased and participates in neuronal apoptotic signaling downstream of caspase-12 during endoplasmic reticulum stress.

Kim EM, Shin EJ, Choi JH, Son HJ, Park IS, Joh TH, Hwang O. Kim EM, et al. J Biol Chem. 2010 May 28;285(22):16444-52. doi: 10.1074/jbc.M109.093799. Epub 2010 Apr 5. J Biol Chem. 2010. PMID: 20368330 Free PMC article.

5

A novel compound PTIQ protects the nigral dopaminergic neurones in an animal model of Parkinson's disease induced by MPTP.

Son HJ, Lee JA, Shin N, Choi JH, Seo JW, Chi DY, Lee CS, Kim EM, Choe H, Hwang O. Son HJ, et al. Among authors: kim em. Br J Pharmacol. 2012 Apr;165(7):2213-27. doi: 10.1111/j.1476-5381.2011.01692.x. Br J Pharmacol. 2012. PMID: 21951056 Free PMC article.

6

Matrix metalloproteinase-3 is activated by HtrA2/Omi in dopaminergic cells: relevance to Parkinson's disease.

Shin EJ, Kim EM, Lee JA, Rhim H, Hwang O. Shin EJ, et al. Among authors: kim em. Neurochem Int. 2012 Feb;60(3):249-56. doi: 10.1016/j.neuint.2012.01.001. Epub 2012 Jan 11. Neurochem Int. 2012. PMID: 22265821

7

Caspase-9 activation and Apaf-1 cleavage by MMP-3.

Kim EM, Shin EJ, Lee JA, Son HJ, Choi DH, Han JM, Hwang O. Kim EM, et al. Biochem Biophys Res Commun. 2014 Oct 24;453(3):563-8. doi: 10.1016/j.bbrc.2014.09.124. Epub 2014 Oct 5. Biochem Biophys Res Commun. 2014. PMID: 25285627

8

Doxycycline is neuroprotective against nigral dopaminergic degeneration by a dual mechanism involving MMP-3.

Cho Y, Son HJ, Kim EM, Choi JH, Kim ST, Ji IJ, Choi DH, Joh TH, Kim YS, Hwang O. Cho Y, et al. Among authors: kim st, kim em, kim ys. Neurotox Res. 2009 Nov;16(4):361-71. doi: 10.1007/s12640-009-9078-1. Epub 2009 Jul 7. Neurotox Res. 2009. PMID: 19582534

9

Protective effect of sulforaphane against dopaminergic cell death.

Han JM, Lee YJ, Lee SY, Kim EM, Moon Y, Kim HW, Hwang O. Han JM, et al. Among authors: kim hw, kim em. J Pharmacol Exp Ther. 2007 Apr;321(1):249-56. doi: 10.1124/jpet.106.110866. Epub 2007 Jan 26. J Pharmacol Exp Ther. 2007. PMID: 17259450

10

Protective effect of bromocriptine against BH4-induced Cath.a cell death involving up-regulation of antioxidant enzymes.

Lim JH, Kim SS, Boo DH, No H, Kang BY, Kim EM, Hwang O, Choi HJ. Lim JH, et al. Among authors: kim ss, kim em. Neurosci Lett. 2009 Feb 27;451(3):185-9. doi: 10.1016/j.neulet.2008.12.056. Epub 2009 Jan 6. Neurosci Lett. 2009. PMID: 19146917

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

527 results

Search Page